IHL 0.00% 4.1¢ incannex healthcare limited

General discussion, page-9288

  1. 1,958 Posts.
    lightbulb Created with Sketch. 4359
    If you are a seller on the primal element of fear

    A couple of my personal thoughts

    1. "Fear is the liar, it activates the enemy"
    2. Do you feel lucky enough to get back in at these levels before;

    > Listing on NASDAQ possibly mid-November

    > IHL-42X (Sleep Apnoea) > UWA & Alfred Trials > Results - New Year.

    > IHL-675A (Wonder Drug) > C-Max S.A Trials > Results Q.2, 2022

    > IHL-216A (TBI) > In-vivo Studies using NFL methodology could be released anytime - Last Quarterly said still ongoing but with the fact we are close to a huge incoming exposure NFL audience, I would think that this one could drop after listing or leading up to Sleep Apnoea results being released.

    > Psi-GAD we know from recent updates Trial starts in 2022. - Recruiting participants from 10th January.

    > New 2nd Psychedelics Trial which has been in development for months. Possibly
    first announcement once listed on the NASDAQ.

    Everyone has their legitimate reasons for selling.

    Personally, I would like to see this thing through to $8.00 - $10.00 or a take-over offer that's acceptable to the BOD.
    I also want to be in this if we get a knock on the door from RESMED if that ever happens! LOL, that would be fun!

    Good luck to all, including all sellers wink.png

 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.